UroGen Pharma URGN Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's short-term investments?
- UroGen Pharma (URGN) reported short-term investments of $30.31M in Q1 2026.
- How has UroGen Pharma's short-term investments changed year-over-year?
- UroGen Pharma's short-term investments decreased by 67.0% year-over-year, from $91.86M to $30.31M.
- What is the long-term trend for UroGen Pharma's short-term investments?
- Over 5 years (2020 to 2025), UroGen Pharma's short-term investments has grown at a -27.7% compound annual growth rate (CAGR), from $49.15M to $9.71M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.